Search Results - "De Sousa, Dorothy"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD by O'Donnell, Denis E, Casaburi, Richard, Frith, Peter, Kirsten, Anne, De Sousa, Dorothy, Hamilton, Alan, Xue, Wenqiong, Maltais, François

    Published in The European respiratory journal (01-04-2017)
    “…Two replicate, double-blind, 6-week, incomplete-crossover studies (MORACTO 1 and 2) assessed the effects of tiotropium/olodaterol on inspiratory capacity and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma by Lamb, David, De Sousa, Dorothy, Quast, Karsten, Fundel-Clemens, Katrin, Erjefält, Jonas S, Sandén, Caroline, Hoffmann, Hans Jürgen, Kästle, Marc, Schmid, Ramona, Menden, Kevin, Delic, Denis

    Published in Respiratory research (22-05-2021)
    “…RORγt is a transcription factor that enables elaboration of Th17-associated cytokines (including IL-17 and IL-22) and is proposed as a pharmacological target…”
    Get full text
    Journal Article
  4. 4

    Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design by Troosters, Thierry, Bourbeau, Jean, Maltais, François, Leidy, Nancy, Erzen, Damijan, De Sousa, Dorothy, Korducki, Lawrence, Hamilton, Alan

    Published in BMJ open (13-04-2016)
    “…IntroductionChronic obstructive pulmonary disease (COPD) is associated with exercise limitation and physical inactivity, which are believed to have significant…”
    Get full text
    Journal Article
  5. 5

    Behaviour-change intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation by Bourbeau, Jean, Lavoie, Kim L, Sedeno, Maria, De Sousa, Dorothy, Erzen, Damijan, Hamilton, Alan, Maltais, François, Troosters, Thierry, Leidy, Nancy

    Published in BMJ open (04-04-2016)
    “…IntroductionChronic obstructive pulmonary disease is generally progressive and associated with reduced physical activity. Both pharmacological therapy and…”
    Get full text
    Journal Article
  6. 6

    Behavioural interventions targeting physical activity improve psychocognitive outcomes in COPD by Lavoie, Kim L, Sedeno, Maria, Hamilton, Alan, Li, Pei-Zhi, De Sousa, Dorothy, Troosters, Thierry, Maltais, François, Bourbeau, Jean

    Published in ERJ open research (01-10-2019)
    “…This study explored the impact of a self-management behaviour modification (SMBM) programme with/without bronchodilators and with/without exercise training…”
    Get full text
    Journal Article
  7. 7

    Mechanisms associated with increased physical activity in patients undergoing self-management behaviour modification in the randomised PHYSACTO trial by Bourbeau, Jean, Sedeno, Maria, Li, Pei Zhi, Troosters, Thierry, Hamilton, Alan, De Sousa, Dorothy, Maltais, François, Erzen, Damijan, Lavoie, Kim L

    Published in ERJ open research (01-01-2021)
    “…In this analysis of the PHYSACTO® study, we assessed the efficacy of a self-management behaviour modification (SMBM) programme to improve physical activity…”
    Get full text
    Journal Article
  8. 8
  9. 9

    ROR[gamma]t inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma by Lamb, David, De Sousa, Dorothy, Quast, Karsten, Fundel-Clemens, Katrin, Erjefält, Jonas S, Sandén, Caroline, Hoffmann, Hans Jürgen, Kästle, Marc, Schmid, Ramona, Menden, Kevin, Delic, Denis

    Published in Respiratory research (22-05-2021)
    “…Background ROR[gamma]t is a transcription factor that enables elaboration of Th17-associated cytokines (including IL-17 and IL-22) and is proposed as a…”
    Get full text
    Journal Article
  10. 10

    Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies by Maltais, François, Kirsten, Anne-Marie, Hamilton, Alan, De Sousa, Dorothy, Voß, Florian, Decramer, Marc

    Published in Respiratory research (06-07-2016)
    “…Two replicate, double-blind, placebo-controlled, 6-week crossover studies assessed the effect of the once-daily long-acting β2-agonist olodaterol 5 μg and…”
    Get full text
    Journal Article